Add Company
Join Now

Jubilant Therapeutics Revenue and Competitors

License our Company Data API

Bedminster, NJ

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Jubilant Therapeutics's estimated annual revenue is currently $2.6M per year.(i)
  • Jubilant Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • Jubilant Therapeutics has 17 Employees.(i)
  • Jubilant Therapeutics grew their employee count by -15% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$8.5M55-21%N/AN/A
#2
$0.2M10%N/AN/A
#3
$8.5M55-29%N/AN/A
#4
$108.5M5002%N/AN/A
#5
$0.8M50%N/AN/A
#6
$0.6M40%N/AN/A
#7
$14.7M68-23%$206.4MN/A
#8
$492.2M1503-15%$568MN/A
#9
$1.1M7-42%N/AN/A
#10
$4.5M290%N/AN/A
Add Company

What Is Jubilant Therapeutics?

Jubilant Therapeutics is a patient-focused biopharmaceutical company advancing potent and selective small molecule modulators to address specific unmet medical needs in oncology and autoimmune diseases. The company’s leadership and scientific team are science-driven executives with global pharma background and experience in advancing innovative drug candidates into the clinic. Jubilant Therapeutics is headquartered in the U.S. with independent board and management, guided by globally renowned KOLs and SAB. Key Therapeutic Areas • Oncology • Auto-immune Disorders Portfolio • Novel PAD4 inhibitors targeting auto-immune disorders • Dual LSD1/HDAC6 inhibitors targeting cancer • Novel small molecule PD-L1 inhibitors • Novel brain penetrating PRMT5 inhibitors targeting cancer

keywords:N/A

N/A

Total Funding

17

Number of Employees

$2.6M

Revenue (est)

-15%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2M20-5%N/A
#2
$1.8M264%N/A
#3
$4.3M280%N/A
#4
$3.7M29-3%N/A
#5
$6M30-9%N/A